Pinnacle Associates’s CME Group CME Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $1.2M | Buy |
4,062
+190
| +5% | +$56.4K | 0.02% | 488 |
|
|
2025
Q4 | $1.06M | Buy |
3,872
+579
| +18% | +$157K | 0.01% | 506 |
|
|
2025
Q3 | $890K | Sell |
3,293
-6
| -0.2% | -$1.63K | 0.01% | 534 |
|
|
2025
Q2 | $909K | Buy |
3,299
+101
| +3% | +$27.5K | 0.01% | 524 |
|
|
2025
Q1 | $848K | Sell |
3,198
-329
| -9% | -$81.2K | 0.01% | 515 |
|
|
2024
Q4 | $819K | Sell |
3,527
-3,380
| -49% | -$777K | 0.01% | 515 |
|
|
2024
Q3 | $1.45M | Buy |
6,907
+3,241
| +88% | +$671K | 0.02% | 404 |
|
|
2024
Q2 | $721K | Sell |
3,666
-1,953
| -35% | -$404K | 0.01% | 520 |
|
|
2024
Q1 | $1.21M | Sell |
5,619
-1,288
| -19% | -$271K | 0.02% | 450 |
|
|
2023
Q4 | $1.45M | Sell |
6,907
-232
| -3% | -$49.5K | 0.02% | 409 |
|
|
2023
Q3 | $1.43M | Sell |
7,139
-361
| -5% | -$71.8K | 0.03% | 401 |
|
|
2023
Q2 | $1.39M | Sell |
7,500
-106
| -1% | -$19.6K | 0.02% | 415 |
|
|
2023
Q1 | $1.46M | Buy |
7,606
+253
| +3% | +$45.8K | 0.03% | 354 |
|
|
2022
Q4 | $1.24M | Buy |
7,353
+825
| +13% | +$143K | 0.03% | 374 |
|
|
2022
Q3 | $1.16M | Buy |
6,528
+977
| +18% | +$193K | 0.03% | 372 |
|
|
2022
Q2 | $1.14M | Buy |
5,551
+651
| +13% | +$138K | 0.02% | 382 |
|
|
2022
Q1 | $1.17M | Sell |
4,900
-5,350
| -52% | -$1.26M | 0.02% | 420 |
|
|
2021
Q4 | $2.34M | Buy |
10,250
+31
| +0.3% | +$6.82K | 0.04% | 329 |
|
|
2021
Q3 | $1.98M | Buy |
10,219
+29
| +0.3% | +$5.88K | 0.04% | 341 |
|
|
2021
Q2 | $2.17M | Sell |
10,190
-650
| -6% | -$137K | 0.04% | 325 |
|
|
2021
Q1 | $2.21M | Sell |
10,840
-400
| -4% | -$78.8K | 0.04% | 307 |
|
|
2020
Q4 | $2.05M | Sell |
11,240
-76
| -0.7% | -$12.9K | 0.04% | 295 |
|
|
2020
Q3 | $1.89M | Sell |
11,316
-49
| -0.4% | -$8.25K | 0.05% | 282 |
|
|
2020
Q2 | $1.85M | Sell |
11,365
-21,550
| -65% | -$3.86M | 0.05% | 279 |
|
|
2020
Q1 | $5.69M | Sell |
32,915
-19,900
| -38% | -$3.96M | 0.17% | 139 |
|
|
2019
Q4 | $10.6M | Sell |
52,815
-605
| -1% | -$124K | 0.23% | 118 |
|
|
2019
Q3 | $11.3M | Buy |
53,420
+48,315
| +946% | +$10.1M | 0.27% | 107 |
|
|
2019
Q2 | $991K | Hold |
5,105
| – | – | 0.02% | 410 |
|
|
2019
Q1 | $840K | Hold |
5,105
| – | – | 0.02% | 443 |
|
|
2018
Q4 | $960K | Sell |
5,105
-750
| -13% | -$139K | 0.02% | 396 |
|
|
2018
Q3 | $997K | Hold |
5,855
| – | – | 0.02% | 415 |
|
|
2018
Q2 | $960K | Hold |
5,855
| – | – | 0.02% | 409 |
|
|
2018
Q1 | $947K | Hold |
5,855
| – | – | 0.02% | 413 |
|
|
2017
Q4 | $855K | Sell |
5,855
-500
| -8% | -$71.2K | 0.02% | 429 |
|
|
2017
Q3 | $862K | Hold |
6,355
| – | – | 0.02% | 417 |
|
|
2017
Q2 | $796K | Hold |
6,355
| – | – | 0.02% | 429 |
|
|
2017
Q1 | $755K | Sell |
6,355
-27
| -0.4% | -$3.25K | 0.01% | 434 |
|
|
2016
Q4 | $736K | Sell |
6,382
-395
| -6% | -$44K | 0.01% | 434 |
|
|
2016
Q3 | $708K | Sell |
6,777
-2,250
| -25% | -$235K | 0.01% | 419 |
|
|
2016
Q2 | $879K | Hold |
9,027
| – | – | 0.02% | 386 |
|
|
2016
Q1 | $867K | Hold |
9,027
| – | – | 0.02% | 381 |
|
|
2015
Q4 | $818K | Buy |
9,027
+27
| +0.3% | +$2.54K | 0.02% | 394 |
|
|
2015
Q3 | $835K | Sell |
9,000
-23
| -0.3% | -$2.19K | 0.02% | 383 |
|
|
2015
Q2 | $840K | Buy |
9,023
+23
| +0.3% | +$2.15K | 0.02% | 398 |
|
|
2015
Q1 | $852K | Sell |
9,000
-3,785
| -30% | -$351K | 0.02% | 393 |
|
|
2014
Q4 | $1.13M | Sell |
12,785
-1,500
| -11% | -$127K | 0.02% | 347 |
|
|
2014
Q3 | $1.14M | Sell |
14,285
-1,500
| -10% | -$113K | 0.02% | 346 |
|
|
2014
Q2 | $1.12M | Sell |
15,785
-545
| -3% | -$38.4K | 0.02% | 347 |
|
|
2014
Q1 | $1.21M | Hold |
16,330
| – | – | 0.02% | 327 |
|
|
2013
Q4 | $1.28M | Hold |
16,330
| – | – | 0.03% | 335 |
|
|
2013
Q3 | $1.21M | Sell |
16,330
-200
| -1% | -$14.7K | 0.02% | 328 |
|
|
2013
Q2 | $1.25M | Buy |
+16,530
| New | +$1.08M | 0.03% | 315 |
|
Other funds holding CME
VCM
VPM
Pinnacle Associates's CME Position: Q1 2026 in Review
Pinnacle Associates increased its CME Group (CME) stake by 4.9% in Q1 2026, buying an estimated $56.4K and bringing the position to 4,062 shares worth $1.2M. The position accounts for 0.02% of the portfolio, ranked #488.
Pinnacle Associates first reported a position in CME in Q2 2013 and has held it in 52 quarters since. The position peaked at $11.3M in Q3 2019. 1,791 funds tracked by Wall St. Rank hold CME as of Q1 2026.
- Pinnacle Associates held 4,062 shares of CME Group worth $1.2M as of Q1 2026.
- Pinnacle Associates bought 190 CME Group shares in Q1 2026, an estimated $56.4K.
- CME Group made up 0.02% of Pinnacle Associates's portfolio in Q1 2026, its #488 holding.
- Pinnacle Associates first reported a position in CME Group in Q2 2013 and has held it in 52 quarters since.
- Pinnacle Associates's CME Group position peaked at $11.3M in Q3 2019.
- 1,791 funds tracked by Wall St. Rank held CME Group as of Q1 2026.
Based on Pinnacle Associates's 13F filing for Q1 2026, filed 22 Apr 2026.